CJ Bioscience

CJ Bioscience Enterprise Value

The Enterprise Value (EV) of CJ Bioscience (311690.KQ) as of Nov 3, 2026 is 105.18 B KRW. In the previous year, Enterprise Value (EV) was 37.40 B KRW — a change of 181.26% (higher).

Enterprise Value

105.18 BKRW

YoY

181.26%

Last updated:

Enterprise Value (EV) of CJ Bioscience is 2025 105.18 B KRW. Enterprise Value (EV) of CJ Bioscience was 2024 37.40 B KRW. It decreases by 181.26% higher compared to the previous year.

The CJ Bioscience Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2018
94.41 B KRW
Jan 1, 2019
74.50 B KRW
Jan 1, 2020
101.48 B KRW
Jan 1, 2021
29.21 B KRW
Jan 1, 2022
62.34 B KRW
Jan 1, 2023
47.75 B KRW
Jan 1, 2024
37.40 B KRW
Jan 1, 2025
105.18 B KRW
The CJ Bioscience Enterprise Value history
YEAREnterprise ValueYoY
105.18 BKRW+181.26%
37.40 BKRW-21.68%
47.75 BKRW-23.41%
62.34 BKRW+113.44%
29.21 BKRW-71.22%
101.48 BKRW+36.22%
74.50 BKRW-21.09%
94.41 BKRW+2.33%
92.26 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

CJ Bioscience Stock analysis

What does CJ Bioscience do? CJ Bioscience Inc is a South Korean company headquartered in Seoul, operating within the health care sector. It engages in the research and development of biotechnology and provides solutions for microbiological research, including biomedicine, institutional research and development, and genetic sequencing. The firm mainly offers microbial bioinformatics analysis services and microbiome-based healthcare services through a bioinformatics database and cloud analytics platform. Additionally, it develops microbiome therapies and infection diagnosis solutions. CJ Bioscience Inc conducted its initial public offering on December 26, 2019. Its website is https://www.cjbioscience.com/. CJ Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CJ Bioscience stock

Enterprise Value (EV) of CJ Bioscience is 105.18 B KRW in 2025.

Enterprise Value (EV) of CJ Bioscience changed from 37.40 B KRW to 105.18 B KRW, representing a 181.26% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) CJ Bioscience since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s KRW, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' KRW varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s CJ Bioscience with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — CJ Bioscience

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — CJ Bioscience